×
Home Current Archive Editorial board
News Contact
Original article

Analysis of excessive corticosteroid use as an indicator of poor quality of care in patients with inflammatory bowel disease

By
Mirela Bašić Denjagić ,
Mirela Bašić Denjagić

Department of Gastroenterology, Clinic for Internal Medicine, University Clinical Centre Tuzla , Tuzla , Bosnia and Herzegovina

Mirna Alečković-Halilović ,
Mirna Alečković-Halilović

Department of Nephrology, Clinic for Internal Medicine, University Clinical Centre Tuzla , Tuzla , Bosnia and Herzegovina

Lejla Rakovac-Tupković Orcid logo ,
Lejla Rakovac-Tupković
Contact Lejla Rakovac-Tupković

Department of Clinical Pharmacology, University Clinical Centre Tuzla , Tuzla , Bosnia and Herzegovina

Predrag Jovanović ,
Predrag Jovanović

Department of Gastroenterology, Clinic for Internal Medicine, University Clinical Centre Tuzla , Tuzla , Bosnia and Herzegovina

Zlatan Mehmedović ,
Zlatan Mehmedović

Clinic for General Surgery; University Clinical Centre Tuzla , Tuzla , Bosnia and Herzegovina

Enver Zerem
Enver Zerem

Department of Medical Sciences, Academy of Science and Arts , Sarajevo , Bosnia and Herzegovina

Abstract

Aim To evaluate the clinical impact of corticosteroids (CS) overuse in inflammatory bowel disease (IBD) patients. Excessive use of CS could delay more efficacious treatment and may indicate poor quality of care.
Method This is a two-phase study that used Steroid Assessment Tool (SAT) to measure corticosteroid exposure in IBD patients. In the first phase data from 211 consecutive ambulatory patients with IBD (91 with ulcerative colitis, 115 with Crohn's disease, and five with unclassified inflammatory bowel disease) were analyzed by SAT. In the second phase, one year after data entry, clinical outcome of patients with cortico-steroids overuse was analysed.
Results Of the 211 IBD patients, 132 (62%) were not on corticosteroids, 45 (22%) were cortico-steroid-dependent and 34 (16%) used corticosteroids appropriately, according to the European Crohn's and Colitis Organization guidelines. In the group of patients with ulcerative colitis, 57 (63%) were not on cortico-steroids, 18 (20%) were corticosteroid-dependent, and 16 (16%) used cortico-steroids appropriate-ly; in the group of patients with Crohn's disease 70 (61%), 27 (23%) and 18 (16%), respectively. Overall, 24 (out of 45; 53%) patients with IBD could avoid the overuse of cortico-steroids if they had a timely change of the treatment, surgery or entered a clinical trial.
Conclusion An excessive corticosteroid use can be recognized on time using the SAT. We have proven that excessive corticosteroid use could be avoided in almost half of cases and thus the overuse of CS may indicate poor quality of care in those patients.

Citation

Funding Statement

No specific funding was received for this study.

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.